Revenue assurance for MedTech.
Identify where your revenue breaks: regulatory, cyber and security risk, clinical efficacy, safety, integration, interfaces, buyers.
Fixed price. Fixed outcome.
14 FDA clearances.
Author, WHO Europe cybersecurity guidance for Digital Health.
Revenue breaks in two ways
Know which type before your deal stalls
Unexamined
- Features listed
- Risks hidden
- Failures on launch
Architected
- Risks computed
- Defensible
- Revenue assured
Where revenue breaks
- Architecture fixed too early
- Interfaces not secured
- Risk mitigation not prioritized
- No go-to-market readiness
You don't see this until customer deployment or regulatory review
This is how we assure your revenue
System to residual risk mapping
SYSTEM
↓
ASSETS
↓
THREATS
↓
COUNTERMEASURES
↓
EXPLOITABILITY
↓
RESIDUAL RISK
System architecture → computed residual risk
Identifies what breaks your revenue, then priorities the fixes.
The OpenCRO system
Foundation
$3K
Model
$6K
Operate
$9K/year
Clear
$43K
Submitting in 6–9 months?
Capacity is limited
We take on a limited number of submissions per quarter.
Q2 Capacity
10
total
7
committed
3
remaining
Each engagement is led directly. We don't outsource the thinking
Who this is for
- Devices generating revenue under compliance pressure
- AI for clinical delivery, diagnosis, monitoring or treatment decisions
- CEOs that want outcomes not billable hours
42 companies have already gone through this system
Fixed outcome. Fixed price.